Belluscura plc (BELL.L)

7.75 0.00 (0.00%) At close: 02:38PM BST

Belluscura plc

15 Fetter Lane
Holbom
London EC4A 1BW
United Kingdom

https://www.belluscura.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 24

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Robert Rauker	CEO & Director	458.41k	N/A	1965
Mr. Simon Neicheril	CFO & Director	N/A	N/A	1959
Mr. Keith Cook	Vice President of Operations	N/A	N/A	N/A
Mr. Robert Fary	Senior Vice President of Global Sales & Executive Director	N/A	N/A	1958
Mr. Jim Clement	Head of Commercial Strategy	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLOR, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.

Corporate governance

Belluscura plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.